Cargando…

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma

Background: The concentration and duration of intracellular drugs have always been the key factors for determining the efficacy of the treatment. Efflux of chemotherapeutic drugs or anticancer agents is a major reason for multidrug resistance generation in cancer cells. The high expression of polyme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Eryan, Wang, Lin, Jin, Weili, Liu, Xing, Wang, Qixue, Wu, Ye, Tan, Yanli, Wang, Yunfei, Cui, Xiaoteng, Zhao, Jixing, Tong, Fei, Hong, Biao, Xiao, Menglin, Liu, Xiaomin, Fang, Chuan, Kang, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169358/ https://www.ncbi.nlm.nih.gov/pubmed/35673568 http://dx.doi.org/10.7150/thno.71763

Ejemplares similares

PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
por: Yi, Kaikai, et al.
Publicado: (2022)

Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A
por: Jin, Weili, et al.
Publicado: (2022)

UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1
por: Cen, Xiaotong, et al.
Publicado: (2022)

The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes
por: Huang, Kai, et al.
Publicado: (2018)

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
por: Cui, Xiaoteng, et al.
Publicado: (2023)

PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis
por: Nassar, Zeyad D., et al.
Publicado: (2013)

IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells
por: Salani, Barbara, et al.
Publicado: (2010)

PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges
por: Liu, Libin, et al.
Publicado: (2016)

TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma
por: Yang, Shixue, et al.
Publicado: (2022)

Co-Regulation of Cell Polarization and Migration by Caveolar Proteins PTRF/Cavin-1 and Caveolin-1
por: Hill, Michelle M., et al.
Publicado: (2012)

Homotrimer cavin1 interacts with caveolin1 to facilitate tumor growth and activate microglia through extracellular vesicles in glioma
por: Wang, Lin, et al.
Publicado: (2020)

PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis
por: Taniguchi, Takuya, et al.
Publicado: (2016)

Expert opinion on translational research for advanced glioblastoma treatment
por: Cui, Xiaoteng, et al.
Publicado: (2023)

Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration
por: Meng, Fanrui, et al.
Publicado: (2015)

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
por: Zhou, Junhu, et al.
Publicado: (2023)

Universal theranostic CRISPR/Cas13a RNA-editing system for glioma
por: Wu, Ye, et al.
Publicado: (2023)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021)

PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics
por: Gámez-Pozo, Angelo, et al.
Publicado: (2012)

Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF
por: Swärd, Karl, et al.
Publicado: (2013)

Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas
por: Wang, Qixue, et al.
Publicado: (2019)

A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature
por: Mancioppi, Valentina, et al.
Publicado: (2023)

Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage
por: Cui, Xiaoteng, et al.
Publicado: (2021)

RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
por: Zhao, Kai, et al.
Publicado: (2019)

Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation
por: Inder, Kerry L., et al.
Publicado: (2014)

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
por: Huang, Kai, et al.
Publicado: (2019)

PTRF suppresses the progression of colorectal cancers
por: Wang, Fengyun, et al.
Publicado: (2016)

Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to PTRF-CAVIN Mutations
por: Rajab, Anna, et al.
Publicado: (2010)

LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis
por: Li, Yansheng, et al.
Publicado: (2021)

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
por: Xu, Can, et al.
Publicado: (2022)

Crispr Library Screening: Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma (Adv. Sci. 17/2019)
por: Huang, Kai, et al.
Publicado: (2019)

Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism
por: Yin, Delong, et al.
Publicado: (2021)

Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme
por: Lin, Yiguang, et al.
Publicado: (2018)

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy
por: Zhan, Qi, et al.
Publicado: (2020)

Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke
por: Jin, Weili, et al.
Publicado: (2021)

Molecular and clinical characterization of PTRF in glioma via 1,022 samples
por: Sun, Si, et al.
Publicado: (2023)

FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury
por: Cai, Ying, et al.
Publicado: (2020)

MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes
por: Bastiani, Michele, et al.
Publicado: (2009)

Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas
por: Yang, Chao, et al.
Publicado: (2019)

Anesthesia for patients with PTRF mutations: a case report
por: Hirano, Atsuko, et al.
Publicado: (2018)

Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia
por: Yang, Eryan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cc1cj06fh9u6b69reo0smmr5us